Wang Benjing, Liu Minjuan, Yan Wenhua, Mao Jun, Jiang Dong, Li Hong, Chen Ying
Center for Reproduction and Genetics, Nanjing Medical University Affiliated Suzhou Hospital , Suzhou, Jiangsu Province 215002 , China.
J Matern Fetal Neonatal Med. 2013 Dec;26(18):1768-77. doi: 10.3109/14767058.2013.799648. Epub 2013 Jun 10.
To investigate the association of 12 single nucleotide polymorphisms (SNPs) in folate metabolic genes with congenital heart disease (CHD).
A total of 160 children with CHD and 188 control children were enrolled. Twelve SNPs related to folate metabolism, including CBS-C699T, DHFR-c594 + 59del19, FOLH1-T1561C, CBS-C699T, DHFR-c594 + 59del19, GSTO1-C428T, MTHFD-G878A and -G1958A, MTHFR-C677T and -A1298C, MTR-A2756G, MTRR-A66G, NFE2L2-ins1 + C11108T, RFC1-G80A, TCN2-C776T and TYMS-1494del6, were genotyped by SNaPShot genotyping technology and confirmed by Sanger sequencing.
There were two SNPs including NFE2L2-ins1 + C11108T and GST01-C428T and two compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR-A2756G), which might increase the risk of CHD, and DHFR-c594 + 59del19 might decrease the risk of CHD. The CT genotype of NFE2L2-ins1 + C11108T, OR = 2.15 (95% CI = [1.07, 4.32], p < 0.05). The CT + TT genotype of NFE2L2-ins1 + C11108T, OR = 1.98 (95% CI = [1.00, 3.93], p < 0.05). The TT genotype of GST01-C428T, OR = 3.49, (95CI% = [1.06, 11.5], p < 0.05). The GG genotype of DHFR-c594 + 59del19, OR = 0.46 (CI% = [0.24, 0.87], p < 0.05). The AG + GG genotype of DHFR-c594 + 59del19, OR = 0.53 (CI% = [0.29, 0.96], p < 0.05). The ratios of the two compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR-A2756G) in CHD are higher than that in control, p < 0.05 (OR = 2.968, 95% CI = [1.022, 8.613]).
The CT genotype of NFE2L2-ins1 + C11108T and the TT genotype of GST01-C428T are susceptible factors for CHD. The AG, GG and (AG + GG) genotypes of DHFR-c594 + 59del19 are protective genotypes for CHD. Compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR-A2756G) may increase the risk of CHD.
探讨叶酸代谢基因中的12个单核苷酸多态性(SNP)与先天性心脏病(CHD)的关联。
共纳入160例先天性心脏病患儿和188例对照儿童。采用SNaPShot基因分型技术对12个与叶酸代谢相关的SNP进行基因分型,包括CBS-C699T、DHFR-c594+59del19、FOLH1-T1561C、CBS-C699T、DHFR-c594+59del19、GSTO1-C428T、MTHFD-G878A和-G1958A、MTHFR-C677T和-A1298C、MTR-A2756G、MTRR-A66G、NFE2L2-ins1+C11108T、RFC1-G80A、TCN2-C776T和TYMS-1494del6,并通过Sanger测序进行验证。
NFE2L2-ins1+C11108T和GST01-C428T这两个SNP以及(MTHFD-G1958A、MTHFR-C677T和MTR-A2756G)和(MTHFD-G1958A、RFC1-G80A和MTR-A2756G)这两个复合突变可能增加CHD风险,而DHFR-c594+59del19可能降低CHD风险。NFE2L2-ins1+C11108T的CT基因型,OR=2.15(95%CI=[1.07,4.32],p<0.05)。NFE2L2-ins1+C11108T的CT+TT基因型,OR=1.98(95%CI=[1.00,3.93],p<0.05)。GST01-C428T的TT基因型,OR=3.49,(95CI%=[1.06,11.5],p<0.05)。DHFR-c594+59del19的GG基因型,OR=0.46(CI%=[0.24,0.87],p<0.05)。DHFR-c594+59del19的AG+GG基因型,OR=0.53(CI%=[0.29,0.96],p<0.05)。CHD中(MTHFD-G1958A、MTHFR-C677T和MTR-A2756G)和(MTHFD-G1958A、RFC1-G80A和MTR-A2756G)这两个复合突变的比例高于对照组,p<0.05(OR=2.968,95%CI=[1.022,8.613])。
NFE2L2-ins1+C11108T的CT基因型和GST01-C428T的TT基因型是CHD的易感因素。DHFR-c594+59del19的AG、GG和(AG+GG)基因型是CHD的保护性基因型。(MTHFD-G1958A、MTHFR-C677T和MTR-A2756G)和(MTHFD-G1958A、RFC1-G80A和MTR-A2756G)复合突变可能增加CHD风险。